DrugPatentWatch Database Preview
Ge Healthcare Company Profile
What is the competitive landscape for GE HEALTHCARE, and when can generic versions of GE HEALTHCARE drugs launch?
GE HEALTHCARE has fifty-four approved drugs.
There are seven US patents protecting GE HEALTHCARE drugs.
There are one hundred and thirteen patent family members on GE HEALTHCARE drugs in thirty-one countries and seventy-three supplementary protection certificates in fifteen countries.
Summary for Ge Healthcare
| International Patents: | 113 |
| US Patents: | 7 |
| Tradenames: | 62 |
| Ingredients: | 42 |
| NDAs: | 54 |
| Drug Master File Entries: | 5 |
| Patent Litigation for Ge Healthcare: | See patent lawsuits for Ge Healthcare |
Drugs and US Patents for Ge Healthcare
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ge Healthcare | HYPAQUE | diatrizoate sodium | INJECTABLE;INJECTION | 009561-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | |||||
| Ge Healthcare | TECHNETIUM TC 99M GENERATOR | technetium tc-99m sodium pertechnetate generator | SOLUTION;INTRAVENOUS, ORAL | 017693-002 | Dec 13, 2013 | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | |||||
| Ge Healthcare | OMNIPAQUE 300 | iohexol | SOLUTION;INJECTION, ORAL, RECTAL | 018956-003 | Dec 26, 1985 | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | |||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for Ge Healthcare
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Ge Healthcare | OMNIPAQUE 350 | iohexol | SOLUTION;INJECTION, ORAL | 018956-004 | Dec 26, 1985 | 4,021,481 | ➤ Try a Free Trial |
| Ge Healthcare | VISIPAQUE 320 | iodixanol | INJECTABLE;INJECTION | 020351-002 | Mar 22, 1996 | 5,349,085 | ➤ Try a Free Trial |
| Ge Healthcare | OPTISON | albumin human | INJECTABLE;INJECTION | 020899-001 | Dec 31, 1997 | 5,573,751 | ➤ Try a Free Trial |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
International Patents for Ge Healthcare Drugs
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Norway | 2015005 | ➤ Try a Free Trial |
| World Intellectual Property Organization (WIPO) | 0216333 | ➤ Try a Free Trial |
| Hong Kong | 1149203 | ➤ Try a Free Trial |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for Ge Healthcare Drugs
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| C0013 | France | ➤ Try a Free Trial | PRODUCT NAME: DASABUVIR OU UN SEL DE CELUI-CI, NOTAMMENT LE SEL DE SODIUM; REGISTRATION NO/DATE: EU/1/14/983 20150119 |
| 2015 00014 | Denmark | ➤ Try a Free Trial | PRODUCT NAME: DASABUVIR OR A SALT THEREOF, INCLUDING DASABUVIR SODIUM MONOHYDRATE; REG. NO/DATE: EU/1/14/983 20150115 |
| C/GB97/078 | United Kingdom | ➤ Try a Free Trial | PRODUCT NAME: MANGAFODIPIR AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, IN PARTICULAR MANGAFODIPIR TRISODIUM; REGISTERED: UK EU/1/97/040/001 19970522; UK EU/1/97/040/002 19970522 |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
